Progressivity of out-of-pocket costs under Australia's universal health care system: A national linked data study.
Autor: | Law HD; National Centre for Epidemiology and Population Health, Australian National University, Building 62, Mills Rd, Acton, ACT 2601, Australia. Electronic address: hsei-di.law@anu.edu.au., Marasinghe D; Centre for Social Research and Methods, Australian National University, Australia., Butler D; National Centre for Epidemiology and Population Health, Australian National University, Building 62, Mills Rd, Acton, ACT 2601, Australia., Welsh J; National Centre for Epidemiology and Population Health, Australian National University, Building 62, Mills Rd, Acton, ACT 2601, Australia., Lancsar E; National Centre for Epidemiology and Population Health, Australian National University, Building 62, Mills Rd, Acton, ACT 2601, Australia., Banks E; National Centre for Epidemiology and Population Health, Australian National University, Building 62, Mills Rd, Acton, ACT 2601, Australia., Biddle N; Centre for Social Research and Methods, Australian National University, Australia., Korda R; National Centre for Epidemiology and Population Health, Australian National University, Building 62, Mills Rd, Acton, ACT 2601, Australia. |
---|---|
Jazyk: | angličtina |
Zdroj: | Health policy (Amsterdam, Netherlands) [Health Policy] 2023 Jan; Vol. 127, pp. 44-50. Date of Electronic Publication: 2022 Oct 21. |
DOI: | 10.1016/j.healthpol.2022.10.010 |
Abstrakt: | Background: In line with affordability and equity principles, Medicare-Australia's universal health care program-has measures to contain out-of-pocket (OOP) costs, particularly for lower income households. This study examined the distribution of OOP costs for Medicare-subsidised out-of-hospital services and prescription medicines in Australian households, according to their ability to pay. Methods: OOP costs for out-of-hospital services and medicines in 2017-18 were estimated for each household, using 2016 Australian Census data linked to Medicare Benefits Schedule (MBS) and Pharmaceutical Benefit Scheme (PBS) claims. We derived household disposable income by combining income information from the Census linked to income tax and social security data. We quantified OOP costs as a proportion of equivalised household disposable income and calculated Kakwani progressivity indices (K). Results: Using data from 82% (n = 6,830,365) of all Census private households, OOP costs as a percentage of equivalised household disposable income decreased from 1.16% in the poorest decile to 0.63% in the richest decile for MBS services, and from 1.35% to 0.35% for PBS medicines. The regressive trend was less pronounced for MBS services (K = -0.06), with percentage OOP cost relatively stable between the 2nd and 9th income deciles; while percentage OOP cost decreased with increasing income for PBS medicines (K = -0.24). Conclusion: OOP costs for out-of-hospital Medicare services were mildly regressive while those for prescription medicines were distinctly regressive. Actions to reduce inequity in OOP costs, particularly for medicines, should be considered. Competing Interests: Declarations of Competing Interest None. (Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |